Axxima Pharmaceuticals AG

Axximaâ„¢ Pharmaceuticals AG (formerly VirGene) is the leader in the application of pathogen-host signal transduction intervention. The company develops proprietary drugs that are based on Axxima's revolutionary approach to generate a Signal Transduction Firewallâ„¢ (STFâ„¢) against pathogens. Axxima's business strategy is to pursue the highly desirable area of anti-infective drug discovery from beginning to end, from target identification to drug development, making it a small pharmaceutical company rather than a traditional platform-based biotechnology startup. Axxima has developed a technology platform directed towards the identification of "critical" interaction points between a pathogen and target cells in the host. Axxima is developing small molecule drugs to interfere at these critical interaction points, thus blocking the pathogen's manipulation of the host cell and leaving the pathogen without the tools with which to establish itself in the host.

Contact Details: Am Klopferspitz 19 Martinsried Bavaria D-82152 Germany Tel: +49 (0) 89 - 740 165 - 0 Fax: +49 (0) 89 - 740 165 - 20 Email: WWW: www.axxima.com/

Recent Publications by Axxima Pharmaceuticals AG:
Advances in anti-viral therapeutics. Hepatitis C virus (HCV) and HIV infections are of high economical...	14th April, 2006	Axxima Pharmaceuticals AG, Max-Lebsche-Platz 32, D-81377 Munich, Germany.	Expert Opin Investig Drugs. 2005 Mar;14(3):343-8. DOI Direct Link
Proteomic characterization of the angiogenesis inhibitor SU6668 reveals multiple impacts on cellular kinase signaling. Knowledge about molecular drug action is critical for the development of...	5th October, 2005	Axxima Pharmaceuticals AG, Munich, Germany.	Cancer Res. 2005 Aug 1;65(15):6919-26. DOI Direct Link
Identification of inhibitors for a virally encoded protein kinase by 2 different screening systems: in vitro kinase assay and in-cell activity assay. The human cytomegalovirus (HCMV) protein kinase pUL97 represents an...	19th August, 2005	Axxima Pharmaceuticals AG, Munich, Germany.	J Biomol Screen. 2005 Feb;10(1):36-45. DOI Direct Link
Host cell targets in HCV therapy: novel strategy or proven practice? The development of novel antiviral drugs against hepatitis C is a...	12th August, 2005	Axxima Pharmaceuticals	Antivir Chem Chemother. 2005;16(2):69-90.
Chemical proteomic analysis reveals alternative modes of action for pyrido[2,3-d]pyrimidine kinase inhibitors. Small molecule inhibitors belonging to the pyrido[2,3-d]pyrimidine class...	21st June, 2005	Axxima Pharmaceuticals AG, 81377 Munchen, Germany.	Mol Cell Proteomics. 2004 Dec;3(12):1181-93. Epub 2004 Oct 8. DOI Direct Link
→View more Axxima Pharmaceuticals AG research publications.

Press Releases on Axxima Pharmaceuticals AG:
GANYMED names Rainer Wessel Ph.D. as President & CEO	1st December, 2003	Ganymed	GANYMED names Rainer Wessel Ph.D. as President & CEO Mainz, Germany (April 1, 2004) - GANYMED Pharmaceuticals AG, an independent biotechnology company with an initial focus on cancer,
CENIX BIOSCIENCE, A PIONEER IN RNAi TECHNOLOGIES, RAISES Euros 5 MILLION	1st January, 1970	Cenix	CENIX BIOSCIENCE, A PIONEER IN RNAi TECHNOLOGIES, RAISES € 5 MILLION IN INTERNATIONAL FINANCING ROUND Dresden, Germany, 10th September, 2002 - Cenix

BioNews Results for Axxima Pharmaceuticals AG:
Siemens AG - Pharmaceuticals & Healthcare - Deals and Alliances Profile - new report released	PR inside:  Nov 13 2009 8:20AM Matching: pharmaceuticals ag
Epigenomics AG - Pharmaceuticals & Healthcare - Deals and Alliances Profile - new report released	PR inside:  Nov 13 2009 9:32PM Matching: pharmaceuticals ag
CNS Pharmaceuticals AG Engages 886 AG as Designated Sponsor	Yahoo! Canada:  Nov 13 2009 8:20AM Matching: pharmaceuticals ag
CNS Pharmaceuticals AG Engages 886 AG as Designated Sponsor	Yahoo! Canada:  Nov 13 2009 8:20AM Matching: pharmaceuticals ag
CNS Pharmaceuticals AG Engages 886 AG as Designated Sponsor	Forbes.com:  Nov 13 2009 8:26AM Matching: pharmaceuticals ag
Promote your company here: BioNewsCast - Press Release Distribution	→View more Axxima Pharmaceuticals AG news.

Contact BioPortfolio for a quote for a customised Excel verision of BioCorporate or BioEmail databases.

This page has been viewed 871 times since April 2007, the link to the organisation's website has been followed 176 times

Recent Search Terms used to find this page: axxima pharmaceuticals | Axxima Pharmaceuticals | Axxima Pharmaceuticals AG | Axxima Pharmaceuticals Ag | Axxima Pharmaceuticals AG Munich Germany | Axxima | AXXIMA Am Klopferspitz 19 | Axxima Pharmaceuticals AG | axxima pharmaceutical AG | Antivir Chem Chemother. 2005 16(2) 69-90 pdf | .

Search for more companies in Martinsried

Search for more companies in Bavaria

This site uses Thumbshots previews, resources from the NCBI applied. Maps are centred on zip/postcodes and should not be relied upon for exact building locations. Some information on this page has been collected automatically and may not have been verified.
BioPortfolio search results for Axxima Pharmaceuticals AG